Is Cerebral Vasospasm still a Clinical Problem?

  • R. W. Seiler
  • R. Binggeli
Conference paper
Part of the Acta Neurochirurgica Supplements book series (NEUROCHIRURGICA, volume 77)


The first International Conference on Cerebral Vasospasm (ICCV) took place in Jackson (Mississippi) in 1972, and the second meeting in Amsterdam in 1979. At that time, ischemic deficits due to cerebral vasospasm (VSP) were a major clinical problem. The International Cooperative Study on the Timing of Aneurysm Surgery evaluated the results of surgical and medical management in 3521 patients treated between 1980 and 1983. The results showed that 42,3% of all patients were dead or disabled, and the leading cause of death and disability was VSP which had been present in 33% of those patients [10], (Fig. 1).


Tranexamic Acid Cerebral Vasospasm Aneurysmal Subarachnoid Hemorrhage Subarachnoid Blood Clinical Vasospasm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Melits DE, Bertsch LA, Boisvert DPJ, Hundley M, Johnson RK, Strom JA, Transou CR (1983) Cerebral arterial spasm — a controlled trial of nimodipine in patients with subarachnoid haemorrhage. N Engl J Med 308: 619–624PubMedCrossRefGoogle Scholar
  2. 2.
    Awad IA, Carter LPH, Spetzler RF, Medina M, William FW Jr (1987) Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 18: 365–372PubMedCrossRefGoogle Scholar
  3. 3.
    Barker FG, Ogilvy CS (1996) Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: meta-analysis. J Neurosurg 84: 404–414Google Scholar
  4. 4.
    Eskridge JM, McAuliffe W, Song JK, Deliganis AV, Newell DW, Lewis DH, Mayberg MR, Winn HR (1998) Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery 42: 510–517PubMedCrossRefGoogle Scholar
  5. 5.
    Farhat SM, Schneider RC (1967) Observations on the effect of systemic blood pressure on intracranial circulation in patients with cerebrovascular insufficiency. J Neurosurg 27: 441–445PubMedCrossRefGoogle Scholar
  6. 6.
    Findlay JM, Weir BKA, Steinke D, Tanabe T, Gordon P, Grace M (1988) Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg 69: 723–735PubMedCrossRefGoogle Scholar
  7. 7.
    Findlay JM, Weir BKA, Kassell NF, Disney LB, Grace MGA (1991) Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 75: 181–188PubMedCrossRefGoogle Scholar
  8. 8.
    Findlay JM, Kassell NF, Weir BKA, Haley EC, Kongable G, Germanson T, Truskowski L, Alves WM, Holness RO, Knuckey NW, Yonas H, Steinberg GK, West M, Winn R, Ferguson G (1995) A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37: 168–178PubMedCrossRefGoogle Scholar
  9. 9.
    Haley EC, Kassell NF, Torner JC, participants (1993) A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 78: 537–547PubMedCrossRefGoogle Scholar
  10. 10.
    Kassell NF, Torner JC, Haley EC, Jane JA, Adams HP, Kongable GL, participants (1990) The International Cooperative Study on the Timing of Aneurysm Surgery. J Neurosurg 73:18–36PubMedCrossRefGoogle Scholar
  11. 11.
    Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP (1982) Treatment of ischemic deficits from vaso-spasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11: 337–343PubMedCrossRefGoogle Scholar
  12. 12.
    Kosnik EJ, Hunt WE (1976) Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg 45: 148–154PubMedCrossRefGoogle Scholar
  13. 13.
    Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, Wu YC, Klebanoff LM, Raps EC, Solomon RA (2000) Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage. A randomized controlled trial. Stroke 31: 303–391CrossRefGoogle Scholar
  14. 14.
    Mizoi K, Yoshimoto T, Takahashi A, Fujiwara S, Koshu K, Sugawara T (1993) Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 78: 430–437PubMedCrossRefGoogle Scholar
  15. 15.
    Öhman J, Heiskanen O (1988) Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 69: 683–686PubMedCrossRefGoogle Scholar
  16. 16.
    Öhman J, Servo A, Heiskanen O (1991) Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75:197–201PubMedCrossRefGoogle Scholar
  17. 17.
    Ljunggren B, Brandt L, Sundbärg G, Saveland H, Cronquist S, Stridbeck H (1982) Early management of aneurysmal subarachnoid hemorrhage. Neurosurgery 11: 414–418Google Scholar
  18. 18.
    Philippon J, Grob R, Dagreou F, Guggiari M, Rivierez M, Viars P (1986) Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir (Wien) 82: 110–114CrossRefGoogle Scholar
  19. 19.
    Pickard JD, Murray GD, Illingworth R, Shaw MDM, Teasdale GM, Foy PM, Humphrey PRD, Lang DA, Nelson R, Richards P, Sinar J, Bailey S, Skene A (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298: 636–642PubMedCrossRefGoogle Scholar
  20. 20.
    Roos YBWEM, de Haan RJ, Beenen LFM, Groen RJM, Albrecht KW, Vermeulen M (2000) Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in The Netherlands. J Neurol Neurosurg Psychiatry 68: 337–341PubMedCrossRefGoogle Scholar
  21. 21.
    Seiler RW, Reulen HJ, Huber P, Grolimund P, Ebeling U, Steiger HJ (1988) Outcome of aneurysmal subarachnoid hemorrhage in a hospital population: A prospective study including early operation, intravenous nimodipine, and transcranial Doppler ultrasound. Neurosurgery 23: 598–604PubMedCrossRefGoogle Scholar
  22. 22.
    Shimoda M, Oda S, Tsugane R, Sato O (1993) Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm. J Neurosurg 78: 423–429PubMedCrossRefGoogle Scholar
  23. 23.
    Solomon RA, Fink ME, Lennihan L (1988) Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage. Neurosurgery 23: 699–704PubMedCrossRefGoogle Scholar
  24. 24.
    Vermeulen M, Lindsay KW, Murray GD, Cheah F, Muizelaar JP, Schannong M, Teasdale GM, van Crevel H, van Gijn J (1984) Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med 311: 432–7PubMedCrossRefGoogle Scholar
  25. 25.
    Zubkov YN, Nikiforov BM, Shustin VA (1984) Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir (Wien) 70: 65–79CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2001

Authors and Affiliations

  • R. W. Seiler
    • 1
  • R. Binggeli
    • 1
  1. 1.Department of NeurosurgeryUniversity HospitalBerneSwitzerland

Personalised recommendations